Here are the top stories you may have missed.
Two of the Top Biotech Stocks with Sizable Catalysts
It's tough to discount the bullish case for biotech and pharmaceutical stocks. For one, millions of retiring baby boomers not only exploring new ways to stave off signs of aging, they are looking to postpone health-related decline and even death. In addition, we're seeing countless mergers and acquisitions. We're also seeing new, innovative treatments for a myriad of issues. And if you're i...
Already a member? Login below, or click here to register now for free.